Introduction: Data regarding the risk of incontinence after cesarean hysterectomy are lacking. We aimed to assess the risk of urinary incontinence in women who underwent planned cesarean hysterectomy for placenta accreta. Methods: This was a retrospective study of women who underwent planned cesarean hysterectomy for placenta accreta. The primary outcome was the incidence of post-cesarean hysterectomy urinary incontinence, defined as involuntary loss of urine between 3 and 12 months after cesarean hysterectomy. Outcomes were compared in a cohort of women who underwent planned cesarean hysterectomy for placenta accreta with a control group of women who underwent scheduled cesarean section without hysterectomy. Results: Forty-seven singleton gestations who underwent planned cesarean hysterectomy for placenta accrete were included in the study and were compared with 100 controls. Eight cases of bladder injuries were reported, 7 in the planned cesarean hysterectomy group and one in the planned cesarean delivery group. Overall, urinary incontinence was reported in 10 women of the planned cesarean hysterectomy group and in 8 women of the planned cesarean section group (21.3% vs. 8.0%; p = 0.03). Conclusion: Planned cesarean hysterectomy for placenta accreta is a risk factor for urinary incontinence.

1.
Xu
P
,
Yong
Q
.
Female urinary incontinence: diagnosis and treatment
.
J Genitourin Res Pract
.
2019
;
1
(
1
):
22
5
.
2.
Temml
C
,
Haidinger
G
,
Schmidbauer
J
,
Schatzl
G
,
Madersbacher
S
.
Urinary incontinence in both sexes: Prevalence rates and impact of quality of life and sexual life
.
Neurourol Urodyn
.
2000
;
19
:
259
71
.
3.
Barrie
MJ
,
Davidson
HA
.
Incontinence in institutions: costs and contributing factors
.
CMAJ
.
1992
;
147
:
322
8
.
4.
Novo
R
,
Perez-Rios
M
,
Santiago-Pérez
MI
,
Butler
H
,
Malvar
A
,
Hervada
X
.
Prevalence and associated risk factors of urinary incontinence and dyspareunia during pregnancy and after delivery
.
Eur J Obstet Gynecol Reprod Biol
.
2019 Nov 27
;
245
:
45
50
. .
5.
Tähtinen
RM
,
Cartwright
R
,
Tsui
JF
,
Aaltonen
RL
,
Aoki
Y
,
Cárdenas
JL
,
Long-term impact of mode of delivery on stress urinary incontinence and urgency urinary incontinence: a systematic review and meta-analysis
.
Eur Urol
.
2016 Jul
;
70
(
1
):
148
58
. .
6.
Crocetto
F
,
Migliorini
S
,
Cancelliere
E
,
Mastantuoni
E
,
Saccone
G
,
Cancelmo
G
,
Risk factors associated with bladder injury at the time of cesarean hysterectomy for placenta accreta
.
Minerva Ginecol
.
2020 Aug 3
;
72
(
6
):
425
6
. Epub ahead of print. PMID: 32744449.
7.
Orbach
A
,
Levy
A
,
Wiznitzer
A
,
Mazor
M
,
Holcberg
G
,
Sheiner
E
.
Peripartum cesarean hysterectomy: critical analysis of risk factors and trends over the years
.
J Matern Fetal Neonatal Med
.
2011 Mar
;
24
(
3
):
480
4
. .
8.
Gielchinsky
Y
,
Rojansky
W
,
Fasouliotis
SJ
,
Ezra
Y
.
Placenta accreta: summary of 10 years: a survey of 310 cases
.
Placenta
.
2002
;
23
:
210
4
.
9.
Wu
S
,
Kocherginsky
M
,
Hibbard
JU
.
Abnormal placentation: twenty-year analysis
.
Am J Obstet Gynecol
.
2005
;
192
:
1458
61
. .
10.
Tam Tam
KB
,
Dozier
J
,
Martin
JN
 Jr
.
Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review
.
J Matern Fetal Neonatal Med
.
2012
;
25
:
329
34
. .
11.
Timmermans
S
,
van Hof
AC
,
Duvekot
JJ
.
Conservative management of abnormally invasive placentation
.
Obstet Gynecol Surv
.
2007
;
62
(
8
):
529
39
. .
12.
Eller
AG
,
Porter
TF
,
Soisson
P
,
Silver
RM
.
Optimal management strategies for placenta accreta
.
BJOG
.
2009
;
116
:
648
54
. .
13.
Ballas
J
,
Hull
AD
,
Saenz
C
,
Warshak
CR
,
Roberts
AC
,
Resnik
RR
,
Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradox
.
Am J Obstet Gynecol
.
2012
;
207
:
216
5
. .e1
14.
Angstmann
T
,
Gard
G
,
Harrington
T
,
Ward
E
,
Thomson
A
,
Giles
W
.
Surgical management of placenta accreta: a cohort series and suggested approach
.
Am J Obstet Gynecol
.
2010
;
202
:
38
9
. .
15.
Verspyck
E
,
Resch
B
,
Sergent
F
,
Marpeau
L
.
Surgical uterine devascularization for placenta accreta: immediate and long-term follow-up
.
Acta Obstet Gynecol Scand
.
2005
;
84
(
5
):
444
7
. .
16.
Pagani
G
,
Cali
G
,
Acharya
G
,
Trisch
IT
,
Palacios-Jaraquemada
J
,
Familiari
A
,
Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis
.
Acta Obstet Gynecol Scand
.
2018 Jan
;
97
(
1
):
25
37
. .
17.
Crocetto
F
,
Esposito
R
,
Saccone
G
,
Della Corte
L
,
Sarno
L
,
Morlando
M
,
Use of routine ureteral stents in cesarean hysterectomy for placenta accreta
.
J Matern Fetal Neonatal Med
.
2019 May 2
:
1
4
.
18.
Simonazzi
G
,
Bisulli
M
,
Saccone
G
,
Moro
E
,
Marshall
A
,
Berghella
V
.
Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials
.
Acta Obstet Gynecol Scand
.
2016 Jan
;
95
(
1
):
28
37
. .
19.
Simonazzi
G
,
Saccone
G
,
Berghella
V
.
Evidence on the use of tranexamic acid at cesarean delivery
.
Acta Obstet Gynecol Scand
.
2016 Jul
;
95
(
7
):
837
. .
20.
Della Corte
L
,
Saccone
G
,
Locci
M
,
Carbone
L
,
Raffone
A
,
Giampaolino
P
,
Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials
.
J Matern Fetal Neonatal Med
.
2018 Sep 10
:
1
6
.
21.
Saccone
G
,
Della Corte
L
,
D’Alessandro
P
,
Ardino
B
,
Carbone
L
,
Raffone
A
,
Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage
.
J Matern Fetal Neonatal Med
.
2019 Jan 31
:
1
9
.
22.
Rappa
C
,
Saccone
G
.
Recurrence of vaginal prolapse after total vaginal hysterectomy with concurrent vaginal uterosacral ligament suspension: comparison between normal-weight and overweight women
.
Am J Obstet Gynecol
.
2016 Nov
;
215
(
5
):
601.e1
4
. .
23.
Yazdany
T
,
Jakus-Waldman
S
,
Jeppson
PC
,
Schimpf
MO
,
Yurteri-Kaplan
LA
,
Ferzandi
TR
,
American urogynecologic society systematic review: the impact of weight loss intervention on lower urinary tract symptoms and urinary incontinence in overweight and obese women
.
Female Pelvic Med Reconstr Surg
.
2020 Jan/Feb
;
26
(
1
):
16
29
. .
24.
Marcelissen
T
,
Anding
R
,
Averbeck
M
,
Hanna-Mitchell
A
,
Rahnama’i
S
,
Cardozo
L
.
Exploring the relation between obesity and urinary incontinence: pathophysiology, clinical implications, and the effect of weight reduction, ICI-RS 2018
.
Neurourol Urodyn
.
2019 Dec
;
38
(
Suppl 5
):
S18
24
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.